You Searched For: Clinical+Analysers

Supplier: CHROMAGAR

Description: Chromogenic technology applied to culture media allows you to differentiate and easily identify, inside one single plate, the growth of different microorganisms.

Supplier: VWR Collection

Description: TraceableGO Bluetooth temperature and humidity dataloggers fill in the unknowns between destinations. Bluetooth device is the ideal transit partner for monitoring materials between destinations. Safely transport reagents, clinical samples, vaccines, pharmaceuticals and food items to any location.

Supplier: Merck

Description: Giemsa's staining is one of the standard procedures in histology, hematology, cytology and bacteriology. The Giemsa's azur-eosin-methylene blue dye is a dry dye that is used for the preparation of a staining solution. This solution can be used for the staining of blood and bone marrow smears, paraffin sections, spirochaets and clinical-cytological specimens of human origin.

Catalog Number: (1.04095.0250)

Supplier: Merck

Description: Glycerol is an aqueous mounting agent for preparation permanent slides of material of human origin or fluorescence microscopy. 100 ml are sufficient for approx. 200 - 300 applications. The mounting agent is an IVD registered product and CE certified, thus can be used for clinical diagnostic purposes.

UOM: 1 * 250 mL

Catalog Number: (BOSSBS-4807R-A488)

Supplier: Bioss

Description: Defects in ATXN3 are the cause of spinocerebellar ataxia type 3 (SCA3) ; also known as Machado-Joseph disease (MJD). Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA3 belongs to the autosomal dominant cerebellar ataxias type I (ADCA I) which are characterized by cerebellar ataxia in combination with additional clinical features like optic atrophy, ophthalmoplegia, bulbar and extrapyramidal signs, peripheral neuropathy and dementia. The molecular defect in SCA3 is the a CAG repeat expansion in ATXN3 coding region. Longer expansions result in earlier onset and more severe clinical manifestations of the disease.

UOM: 1 * 100 µl

Catalog Number: (TUTTTSM260M)

Supplier: TUTTNAUER

Description: Impulse sealing unit for sealing of medical products. Sterilisation of medical instruments is a critically important activity in medicine and dentistry, as well as in veterinary surgeries, hospitals, clinics and laboratories.

UOM: 1 * 1 items

Supplier: NITRITEX

Description: These disposable aprons are made of CleanTough™ fabric, a spunbonded non woven PP fabric laminated with a PE film.

Catalog Number: (BOSSBS-7974R-CY5.5)

Supplier: Bioss

Description: The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. ATX2 belongs to the autosomal dominant cerebellar ataxias type I (ADCA I) which are characterized by cerebellar ataxia in combination with additional clinical features like optic atrophy, ophthalmoplegia, bulbar and extrapyramidal signs, peripheral neuropathy and dementia. ATX2 is caused by expansion of a CAG repeat in the coding region of ATX2. Longer expansions result in earlier onset of the disease. There are four named isoforms.

UOM: 1 * 100 µl

Catalog Number: (BOSSBS-7974R-CY3)

Supplier: Bioss

Description: The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. ATX2 belongs to the autosomal dominant cerebellar ataxias type I (ADCA I) which are characterized by cerebellar ataxia in combination with additional clinical features like optic atrophy, ophthalmoplegia, bulbar and extrapyramidal signs, peripheral neuropathy and dementia. ATX2 is caused by expansion of a CAG repeat in the coding region of ATX2. Longer expansions result in earlier onset of the disease. There are four named isoforms.

UOM: 1 * 100 µl

Catalog Number: (114-9707)

Supplier: VWR Collection

Description: VWR® Disposable cleanroom socks are designed to provide all day comfort inside a cleanroom. They are made from materials that prevent any particle generation while in use.

UOM: 1 * 400 PAIR

New Product

Catalog Number: (170082UA)

Supplier: VWR Chemicals

Description: For various microbiological applications.

UOM: 1 * 30 items

MSDS Certificates

Supplier: THERMO FISHER DIAGNOSTICS

Description: IMAGEN™ is a qualitative direct immunofluorescence test used for detection and confirmation of the presence of virus in cell culture or in clinical specimen.

Catalog Number: (BOSSBS-4807R)

Supplier: Bioss

Description: Defects in ATXN3 are the cause of spinocerebellar ataxia type 3 (SCA3) ; also known as Machado-Joseph disease (MJD). Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA3 belongs to the autosomal dominant cerebellar ataxias type I (ADCA I) which are characterized by cerebellar ataxia in combination with additional clinical features like optic atrophy, ophthalmoplegia, bulbar and extrapyramidal signs, peripheral neuropathy and dementia. The molecular defect in SCA3 is the a CAG repeat expansion in ATXN3 coding region. Longer expansions result in earlier onset and more severe clinical manifestations of the disease.

UOM: 1 * 100 µl

Catalog Number: (BOSSBS-7974R-CY7)

Supplier: Bioss

Description: The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. ATX2 belongs to the autosomal dominant cerebellar ataxias type I (ADCA I) which are characterized by cerebellar ataxia in combination with additional clinical features like optic atrophy, ophthalmoplegia, bulbar and extrapyramidal signs, peripheral neuropathy and dementia. ATX2 is caused by expansion of a CAG repeat in the coding region of ATX2. Longer expansions result in earlier onset of the disease. There are four named isoforms.

UOM: 1 * 100 µl

Supplier: Merck

Description: Histosec® pastilles (without DMSO) is an embedding medium for histology of samples of human origin. It is a paraffin enriched with polymers, also available with the addition of DMSO (dimethyl sulfoxide). DMSO increases the rate of penetration of paraffin and provides additional preservation of the tissue structures. Its melting range is between 56 - 58 °C and, within this range any specimen can be processed without fear of damage irrespective of the method used.
In most clinical laboratories the paraffinization is performed with an automated embedding system and is performed directly after the histoprocessing.

Catalog Number: (BOSSBS-7974R-A350)

Supplier: Bioss

Description: The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. ATX2 belongs to the autosomal dominant cerebellar ataxias type I (ADCA I) which are characterized by cerebellar ataxia in combination with additional clinical features like optic atrophy, ophthalmoplegia, bulbar and extrapyramidal signs, peripheral neuropathy and dementia. ATX2 is caused by expansion of a CAG repeat in the coding region of ATX2. Longer expansions result in earlier onset of the disease. There are four named isoforms.

UOM: 1 * 100 µl